Spectral counting assessment of protein dynamic range in cerebrospinal fluid following depletion with plasma-designed immunoaffinity columns

Clinical Proteomics

Volumn 8, Issue 1, 2011, Pages

  Borg, Jacques ^a   Campos, Alex ^b   Diema, Claudio ^c   Omeñaca, Núria ^c   De Oliveira, Eliandre ^b   Guinovart, Joan ^c   Vilaseca, Marta ^c  

^a UNIVERSITÉ JEAN MONNET   (France)

^b Proteomics Platform   (Spain)

^c INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

Author keywords

APEX; Biomarkers; CSF; depletion column; enrichment; low abundance proteins

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER;

ALGORITHM; ANTIBODY AFFINITY; ARTICLE; CELL FRACTIONATION; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEOMICS; REPRODUCIBILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; SPECTROSCOPY;

EID: 84860625820     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-8-6     Document Type: Article

References (22)

1. Clinical proteomics of CSF: towards discovery of new biomarkers. Roche S, Gabelle A, Lehmann S, Proteomics Clin Appl 2008 2 428 436 10.1002/prca. 200780040 21136844 (Pubitemid 351425370)
2. Detection of biomarkers with a multiplex quantitative proteomic platform in CSF of patients with neurodegenerative disorders. Abdi F, Quinn JF, Jankovic J, et al. J Alzheimers Dis 2006 9 293 348 16914840 (Pubitemid 44253348)
3. Contribution of protein fractionation to depth of analysis of serum and plasma proteomes. Faca V, Pitteri SJ, Newcomb L, Glukhova V, et al. J Proteome Res 2007 6 3558 65 10.1021/pr070233q 17696519 (Pubitemid 47522747)
4. Proteomics analysis of human CSF. Yuan X, Desiderio DM, J Chromatogr 2005 815 179 89 10.1016/j.jchromb.2004.06.044 (Pubitemid 40126400)
5. Quantitative proteomic analysis of age-related changes in human CSF. Zhang J, Goodlett DR, Peskind ER, Quinn JF, et al. Neurobio Aging 2005 26 207 227 10.1016/j.neurobiolaging.2004.03.012 (Pubitemid 39610462)
6. Integrated analysis of CSF peptidome and proteome. Zougman A, Pilch B, Podtelejnikov A, Kiehntopf M, et al. J Proteome Res 2008 7 386 399 10.1021/pr070501k 18052119 (Pubitemid 351171153)
7. In-depth exploration of CSF by combining peptide ligand library treatment and label-free protein quantification. Mouton Barbosa E, Roux-Dalvai F, Bouyssie D, Berger F, et al. Mol Cell Proteomics 2010 9 1006 21 10.1074/mcp.M900513-MCP200 20093276
8. A combined dataset of human CSF proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Pan S, Zhu D, Quinn JF, Peskind ER, et al. Proteomics 2007 7 469 473 10.1002/pmic.200600756 17211832 (Pubitemid 46293989)
9. Establishing the proteome of normal human CSF. Schutzer SE, Liu T, Natelson BH, Angel TE, et al. PLoSOne 2010 5 10980
10. Evaluation of Multiprotein Immunoaffinity Subtraction for Plasma Proteomics and Candidate Biomarker Discovery Using Mass Spectrometry. Liu T, Qian WJ, Mottaz HM, Gritsenko MA, et al. Molecular & Cellular Proteomics 2006 5 2167 2174 10.1074/mcp.T600039-MCP200 21644250 (Pubitemid 44817028)
11. Depletion of high-abundant proteins in body fluids prior to liquid chromatography fourier transform ion cyclotron resonance mass spectrometry. Ramstrom M, Hagman C, Mitchell JK, Derrick PJ, Hakansson P, Bergquist J, J Proteome Res 2005 4 410 6 10.1021/pr049812a 15822917 (Pubitemid 40548146)
12. Assessment of the partitioning capacity of high abundant proteins in human CSF using affinity and immunoaffinity subtraction spin columns. Wetterhall M, Zuberovic A, Hanrieder J, Bergquist J, J Chromatography 2010 878 1519 1530 10.1016/j.jchromb.2010.04.003
13. Assessment approach for evaluating high abundance protein depletion methods for CSF proteomic analysis. Shores KS, Knapp DR, J Proteome Res 2007 6 3739 51 10.1021/pr070293w 17696521 (Pubitemid 47522762)
14. Enhanced detection of CNS cell secretome in plasma protein-depleted CSF. Thouvenot E, Urbach S, Dantec C, Poncet J, Seveno M, Demettre E, J Proteome Res 2008 7 4409 21 10.1021/pr8003858 18774838
15. Characterization of proteome of human CSF. Xu J, Chen J, Peskind ER, Jin J, et al. Int Rev Neurobiol 2006 73 29 98 16737901
16. Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Lu P, Vogel C, Wang R, Yao X, Marcotte EM, Nat Biotechnol 2007 25 117 24 10.1038/nbt1270 17187058 (Pubitemid 46087910)
17. Calculating absolute and relative protein abundance from mass spectrometry-based protein expression data. Vogel C, Marcotte EM, Nat Protoc 2008 3 1444 51 18772871
18. The effects of shared peptides on protein quantitation in label-free proteomics by LC/MS/MS. Jin S, Daly DS, Springer DL, Miller JH, J Proteome Res 2008 7 164 9 10.1021/pr0704175 18001079 (Pubitemid 351171128)
19. Comparison of the performance of two affinity depletion spin filters for quantitative proteomics of CSF: Evaluation of sensitivity and reproducibility of CSF analysis using GeLC-MS/MS and spectral counting. Fratantoni SA, Piersma SR, Jimenez CR, Proteomics Clin Appl 2010 4 613 617 10.1002/prca.200900179 21137079
20. Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: The more the better? Roche S, Tiers L, Provansal M, Sevenod M, et al. J Proteomics 2009 72 945 951 10.1016/j.jprot.2009.03.008 19341827
21. Semisupervised model-based validation of peptide identifications in mass spectrometry-based proteomics. Choi H, Nesvizhskii AI, J Proteome Res 2008 7 254 65 10.1021/pr070542g 18159924 (Pubitemid 351171138)
22. SuperHirn-a novel tool for high resolution LC-MS-based peptide/protein profiling. Mueller LN, Rinner O, Schmidt A, Letarte S, et al. Proteomics 2007 7 3470 80 10.1002/pmic.200700057 17726677 (Pubitemid 47597670)